GAMIFANT
Active substance: emapalumab
INJECTION · EMAPALUMAB 100 mg/20mL
United StatesActive
Marketing holder: Swedish Orphan Biovitrum AB (publ)
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- EMAPALUMAB · 100 mg/20mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-9bb4-7d20-8312-06d79a02feb3,01a1208d-7c67-78a0-9e9c-ffd973402680,01a12090-8cb3-758c-ad0b-75890a19a257,01a12090-8cb4-7caa-ab80-d1d5b71c5505,01a12090-8cb8-741b-88b6-b2e80a405346;count=7 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 66658-510
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 66658-510 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 66658-510 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 66658-510 · Verified 2026-10-09 · open in source